Silver Book Fact

Around 75 – 100 experimental therapies that are aimed at slowing or stopping the progression of Alzheimer’s disease are currently in clinical trials.

Alzheimer's Association. 2011 Alzheimer’s Disease Facts and Figures. Alzheimers Dement. 2011; 7(2): 208-44. http://www.alzheimersanddementia.com/article/S1552-5260(11)00036-7/fulltext

Reference

Title
2011 Alzheimer’s Disease Facts and Figures
Publication
Alzheimers Dement
Publication Date
2011
Authors
Alzheimer's Association
Volume & Issue
Volume 7, Issue 2
Pages
208-44
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Deep Brain Stimulation for Parkinson’s Adds QALYs and Saves Money
     
  • Impact of a 5-Year Delay in Onset by Stage of Disease, Americans Age 65 and Older with Alzheimer’s Disease, 2050  
  • Donepezil, a cholinesterase inhibitor, has been found to slow progression of Alzheimer’s disease in its early stages, delaying the need for nursing home care by an average of 30 months.  
  • According to the Pharmaceutical Research and Manufacturers of America, because of medical research, the number of Americans with Alzheimer’s could decrease by 3 million in 2025.  
  • Impact of Slowed Progression by Stage of Disease, Americans Age 65 and Older with Alzheimer’s Disease, 2050